Skip to main content

Series B Biotechnology Companies

Explore 430 biotechnology startups that raised series b funding. Access verified founder contact information and fundraising data.

Total Companies
430
Total Funding
$1.3B
Avg Funding
$52.7M
Cities
22

Export 430 Series B Biotechnology Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Seoul, South Korea
$4.5M
raised

Plcoskin is a MedTech company specializing in reconstructive plastic surgery and regenerative skincare.

Aug 2023
Series B

Founder Contacts

41,000+ verified contacts

Durham, United States
$6.5M
raised

Cell Microsystems develops, manufactures, and markets innovative products for single-cell biology.

Aug 2023
Series B

Founder Contacts

41,000+ verified contacts

Goleta, United States
$8.0M
raised

True Digital Surgery builds a 3D digital surgery visualization platform that improves visualization for a wide range of surgical procedures.

Aug 2023
Series B

Founder Contacts

41,000+ verified contacts

Albuquerque, United States
$5.4M
raised

BioFlyte is a biodefense company that commercializes a new class of fieldable biological threat collection.

Aug 2023
Series B

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$109.0M
raised

Alltrna is the creator of a tRNA platform that aims to decipher tRNA biology and pioneer therapies for disease treatment.

Aug 2023
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 430 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Berkeley, United States
$60.0M
raised

Kyverna Therapeutics is pioneering a new class of therapies and cures for serious autoimmune diseases.

Aug 2023
Series B

Founder Contacts

41,000+ verified contacts

Planegg, Germany
$11.0M
raised

Bind-X develops biotechnology applications to improve the sustainability of industries by optimizing biotechnological processes.

Aug 2023
Series B

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$32.0M
raised

SURGE Therapeutics seeks to dramatically improve cancer patient survival by disrupting cancer immunotherapy is deployed.

Jul 2023
Series B

Founder Contacts

41,000+ verified contacts

Ljubljana, Slovenia
$22.4M
raised

GenePlanet is a European company active in the field of biotechnology, specializing in genetic testing and research.

Jul 2023
Series B

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$150.0M
raised

Septerna is a biotech firm unlocking diverse drug discovery potential in G protein-coupled receptors across various diseases.

Jul 2023
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 430 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Boston, United States
$30.0M
raised

Allotex offers therapeutic solutions for the treatment of presbyopia and hyperopia.

Jul 2023
Series B

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$70.0M
raised

K36 Therapeutics translate epigenetic modulation of oncogenic pathways into small molecule therapies.

Jun 2023
Series B

Founder Contacts

41,000+ verified contacts

Singapore, Singapore
$41.6M
raised

Lion TCR is a clinical-stage biotechnology company.

Jun 2023
Series B

Founder Contacts

41,000+ verified contacts

Seattle, United States
$52.9M
raised

AltPep provides a novel approach for tackling amyloid diseases, with diagnostic, therapeutic and anti-biofilm applications.

Jun 2023
Series B

Founder Contacts

41,000+ verified contacts

Columbus, United States
$7.7M
raised

Invirsa develops a molecule that promotes ocular DNA repair and the innate immune response to infection and injury.

Jun 2023
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 430 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Bethesda, United States
$12.0M
raised

Adaptive Phage Therapeutics provides therapeutic services intended to treat multi-drug resistant pathogenic bacteria.

Jun 2023
Series B

Founder Contacts

41,000+ verified contacts

New York, United States
$31.5M
raised

AgNovos is a regenerative technology that restores the structure and biomechanics of bone to transform the paradigm of care for osteoporosis

Jun 2023
Series B

Founder Contacts

41,000+ verified contacts

Waltham, United States
$200.0M
raised

Upstream Bio focuses on developing an antibody therapy for the treatment of severe asthma.

Jun 2023
Series B

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$150.0M
raised

Alkeus Pharmaceuticals is a Boston-based startup focused on treatments for serious ophthalmic conditions.

Jun 2023
Series B

Founder Contacts

41,000+ verified contacts

Marietta, United States
$20.0M
raised

Artelon provides kinematic reinforcement of tendon and ligament reconstruction using specifically designed bio-textiles.

May 2023
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 430 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Watertown, United States
$86.6M
raised

Nido Biosciences is a clinical-stage company that develops precision medicines for severe neurological diseases.

May 2023
Series B

Founder Contacts

41,000+ verified contacts

Brooklyn, United States
$15.0M
raised

Kinnos is a biotechnology company that makes it easy to use disinfectants correctly.

May 2023
Series B

Founder Contacts

41,000+ verified contacts

Toronto, Canada
$25.0M
raised

ODAIA is driving next-generation customer engagement with the leading AI-fueled Customer Data Platform for the Life Sciences industry.

May 2023
Series B

Founder Contacts

41,000+ verified contacts

London, United Kingdom
$25.1M
raised

Polymateria is a startup advancing science to help nature deal with plastic pollution.

Apr 2023
Series B

Founder Contacts

41,000+ verified contacts

Vancouver, Canada
$142.0M
raised

Abdera is an oncology company developing targeted alpha therapies (TATs) for patients with relapsed, refractory, and metastatic cancers.

Apr 2023
Series B

Founder Contacts

41,000+ verified contacts

Showing 276 to 300 of 430 companies

Ready to Connect with Series B Biotechnology Startups?

Get verified founder emails, funding details, and company data for 430 series b biotechnology companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

430 Biotechnology Series B Startups (November 2026) — Page 12 | VCBacked